DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2019366)

From EU Knowledge Graph
Revision as of 21:08, 22 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations)
Jump to navigation Jump to search
Project Q2019366 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX
Project Q2019366 in Italy

    Statements

    0 references
    986,675.87 Euro
    0 references
    1,329,656.71 Euro
    0 references
    74.21 percent
    0 references
    1 November 2016
    0 references
    31 December 2018
    0 references
    NOUSCOM SOCIETA' A RESPONSABILITA' LIMITATA
    0 references
    0 references
    BIOTECNOLOGIE (Italian)
    0 references
    BIOTECHNOLOGY (English)
    0 references
    BIOTECHNOLOGIE (French)
    14 December 2021
    0 references
    BIOTECHNOLOGIE (Dutch)
    22 December 2021
    0 references

    Identifiers

    B88I17000390008
    0 references